Cintas ( CTAS) estimates, target lowered at Barclays through 2010. Company warned of lower domestic results, hurt by economic conditions. Equal-weight rating and new $20 price target.

Foster Wheeler ( FWLT) target raised at UBS to $30. Company is seeing rising oil prices and has a strong balance sheet. Buy rating.

Guess ( GES) target raised at Credit Suisse to $33 from $25. International growth opportunities, an overestimation of risk, and improved flexibility has led to the target increase. Maintained Outperform rating.

J. Crew ( JCG) numbers raised at UBS to $26. Estimates also increased, as the company posted a strong quarter and has clean inventory levels. Neutral rating.

Mosaic ( MOS) 2009 estimates trimmed at Goldman to $4.21 from $4.31 due to weaker potash pricing. Fertilizer demand remains lackluster, and prices are expected to be hurt by oversupply. China's entrance into phosphate market would likely create further price pressure. Maintained Neutral rating and $45 target.

OSI Pharma ( OSIP) numbers cut at UBS to $41. Estimates also lowered, to reflect as Saturn trial data did not look sufficient. Buy rating.

Wells Fargo ( WFC) estimates raised at Morgan Stanley through 2011. Company is likely seeing higher mortgage banking and investment banking revenue. Overweight rating and $44 price target.

Weyerhaeuser ( WY) target cut at Credit Suisse to $34 from $35 citing a 25% collapse in sawlog prices. Maintained Neutral rating.
This article was written by a staff member of TheStreet.com.

If you liked this article you might like

Equifax Breach Reveals Frightening Truth: Companies Can Delay Disclosing Hacks

How Alibaba's 'Genie' Smart Speaker Can Overcome the Amazon Echo's 3-Year Head Start and Still Win

Facebook, Apple, Netflix and Google Have Caught the Flu -- Here's How Not to Get Killed By It

How to Play the Coming 'FANG Flu'

Travis Kalanick and the Terrible, Horrible, No Good, Very Bad Week